Scientists track drug levels in severe colitis patients
NCT ID NCT03765450
First seen Jun 10, 2026 · Last updated Jun 10, 2026
Summary
This study looks at how the drug infliximab behaves in people hospitalized with severe ulcerative colitis. Researchers measure drug levels in blood, stool, and colon tissue to understand how it works. About 18 adults will take part, and the goal is to learn more about the drug's movement in the body, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SEVERE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornell University
New York, New York, 10065, United States
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
-
UCSD
San Diego, California, 92037, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.